Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Chemistry of anti-AIDS and anticancer compounds

Thesis/Dissertation ·
OSTI ID:7042691

Several types of prodrugs of 2[prime], 3[prime]-dideoxynucleosides were designed and synthesized for evaluation as anti-AIDS drugs. These prodrugs include 5[prime]-O-acyl-2[prime], 3[prime]-dideoxynucleosides, in which the acyl groups are derived from both aromatic and aliphatic acids, [alpha]-amino acids, diacylglycerol carbonic acids, and diacylglycerol carbamic acids. By applying the pyridium-dihydropyridine redox delivery system to deliver 2[prime], 3[prime]-dideoxynucleosides to the central nervous system, 1,4-dihydropyridine-2[prime], 3[prime]-dideoxy-inosine and -adenosine compounds were synthesized. 5[prime]-Esters of 2[prime], 3[prime]-dideoxyinosine and 2[prime], 3[prime]-dideoxyadenosine were evaluated for their activity against the HIV-1 virus and for delivery to the central nervous system (CNS). The isomerization, hydrolysis, and oxidation of alkyl 1,4-dihydro-N-methylpyridine-3-carboxylates were studied by [sup 1]H and [sup 13]C NMR spectroscopy. Three intermediates, 1,4-dihydro-N-methylpyridine-3-carboxylic acid, alkyl (methyl or isopropyl) 1,6-dihydro-N-methylpyridine-3-carboxylate, and 1,6-dihydro-N-methylpyridine-3-carboxylic acid, were observed by [sup 1]H and [sup 13]C NMR spectroscopy, and their percentages in solution were determined. The structures of the 1,6-dihydropyridine intermediates were confirmed by comparison of the NMR spectra with those of an authentic model compound, methyl N-(4-chlorobenzyl)-1,6-dihydropyridine-3-carboxylate. The rate of hydrolysis of alkyl 1,4-dihydro-N-methylpyridine-3-carboxylates depends on the steric bulk of the O-alkyl group. A new type of 1,4-dihydropyridine drug delivery system with a three-carbon spacer group, 9-[2,3-di-O-acetyl-5-O-[3-(1,4-dihydro-N-methylpyridine-3-carboxamido)propionyl]-[beta]-D-arabinofuranosyl]adenine was designed, synthesized, and evaluated to deliver ara-ADA to the CNS for treatment of herpes encephalitis.

Research Organization:
Alabama Univ., Birmingham, AL (United States)
OSTI ID:
7042691
Country of Publication:
United States
Language:
English